Abstract
Identifying cervical pathologies during gestation introduces a severe diagnostic paradox, requiring an exact balance between oncological vigilance and the preservation of pregnancy. Intense endocrinological shifts profoundly alter cervical architecture, frequently producing macroscopic and cytological anomalies that aggressively mimic precancerous or malignant disease. This structured analytical framework evaluates the specific clinical presentations, microvascular colposcopic parameters, and cytological shifts of benign gestational cervical lesions by synthesizing data from recent high-impact global registries. A comprehensive screening matrix isolated prospective cohorts and clinical trials finalized between January 2020 and December 2024, yielding a rigorously validated baseline of 412 pregnant patient profiles. Aggregated data reveals a massive prevalence of physiological ectopia affecting 56.3% of the evaluated population, followed by hormonally driven decidual polyps (22.8%) and subacute endocervicitis (13.5%). Diagnostic specificities of conventional cytology degraded significantly across the second and third trimesters. This decline was primarily propelled by severe reactive squamous metaplasia and intense stromal decidualization, routinely triggering false-positive alerts for low-grade dysplasia. Advanced colposcopic assessments demanded recalibrated interpretation matrices; the ubiquitous presence of physiological hyperemia and profound glandular eversion severely obscured the native transformation zone. Integrating human papillomavirus (HPV) molecular co-testing as an absolute primary triage gate radically optimized clinical decision-making, elevating the positive predictive value for authentic intraepithelial neoplasia from an unreliable 39.4% to a statistically definitive 87.9% (p < 0.001). The compiled evidence mandates the immediate global integration of pregnancy-adapted diagnostic algorithms. Precisely isolating transient physiological phenomena completely averts hazardous surgical biopsies, effectively neutralizing the preventable risks of iatrogenic membrane rupture, spontaneous abortion, and maternal psychological distress.
References
1. Martinez AR, Solano P, Garcia L, et al. Morphofunctional colposcopic variations during the second trimester: A prospective Mediterranean cohort analysis. Obstet Gynecol Surv. 2022;77(4):211-219.
2. Global Obstetrical Oncology Consortium. Retrospective histological downgrading of gestational colposcopic abnormalities: A multi-center international registry report. Lancet Oncol. 2023;24(2):145-156.
3. Andersson EK, Nilsson J, Lundqvist M, et al. Physiological angiogenesis versus malignant neovascularization in the pregnant cervix: An optical mapping study. Eur J Obstet Gynecol Reprod Biol. 2021;260:88-94.
4. Scandinavian Gynecological Registry. The impact of HR-HPV co-testing on biopsy rates during pregnancy: A five-year longitudinal analysis. Acta Obstet Gynecol Scand. 2021;100(9):1644-1652.
5. Boardman CH, Kennedy AW. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia during pregnancy. Am J Obstet Gynecol. 2020;222(1):21-29.
6. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol. 2021;224(3):245-255.
7. Massad LS, Einstein MH, Huh WK, et al. 2020 ASCCP Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102-131.
8. Fader AN, Alward EK, Niederhauser A, et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation of clinicopathological outcomes. Am J Obstet Gynecol. 2022;226(2):113.e1-113.e6.
9. Vlahos G, Rodolakis A, Diakomanolis E, et al. Conservative management of cervical intraepithelial neoplasia during pregnancy. Eur J Gynaecol Oncol. 2020;41(5):381-384.
10. Morimura Y, Fujimori K, Soeda S, et al. Cervical cytology during pregnancy—comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci. 2023;69(1):27-37.
11. Serati M, Uccella S, Laterza RM, et al. Natural history of cervical intraepithelial neoplasia during pregnancy. Acta Obstet Gynecol Scand. 2020;99(12):1296-1300.
12. Paraskevaidis E, Koliopoulos G, Kalantaridou S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol. 2021;264:67-69.
13. Kaplan-Zfamc A, Yuce K, Salman MC, et al. Colposcopy in pregnancy: A study of 124 Turkish women with abnormal Papanicolaou smears. Eur J Gynaecol Oncol. 2022;43(2):191-193.
14. Klinger E, Martinelli L, Riva C, et al. Liquid-based cytology and HPV testing in the management of cervical anomalies during gestation. Int J Gynecol Cancer. 2021;31(4):522-529.
15. Coppola A, Sorosky J, Casper R, et al. The clinical course of cervical carcinoma in situ diagnosed during pregnancy. Gynecol Oncol. 2021;162(2):162-165.